Overview

Effects of Roxithromycin on Quality of Life and Physiological Outcomes in Bronchiectasis

Status:
Completed
Trial end date:
2011-09-30
Target enrollment:
Participant gender:
Summary
roxithormycin 300 mg per day for 12 weeks could improve quality of life and physiological outcomes in bronchiectasis
Phase:
Phase 3
Details
Lead Sponsor:
Prince of Songkla University
Treatments:
Roxithromycin